Alerus Investment Advisors’s Novartis NVS Stock Holding History

Alerus Investment Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$9K	Sell	142 -8,035	-98%	-$547K	﹤0.01%	156
2015 Q4	$582K	Buy	8,177 +3,091	+61%	+$246K	0.1%	106
2015 Q3	$419K	Buy	5,086 +803	+19%	+$71.5K	0.07%	103
2015 Q2	$379K	Hold	4,283	–	–	0.06%	110
2015 Q1	$379K	Buy	4,283 +990	+30%	+$87.8K	0.06%	109
2014 Q4	$274K	Sell	3,293 -88	-3%	-$7.29K	0.05%	117
2014 Q3	$285K	Sell	3,381 -1,987	-37%	-$161K	0.05%	115
2014 Q2	$435K	Sell	5,368 -1,168	-18%	-$91.9K	0.08%	107
2014 Q1	$498K	Buy	6,536 +6,196	+1,822%	+$451K	0.11%	109
2013 Q4	$24K	Buy	+340	New	+$23.6K	0.01%	139

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Alerus Investment Advisors's NVS Position: Q1 2016 in Review

Alerus Investment Advisors reduced its Novartis (NVS) stake by 98% in Q1 2016, selling an estimated $547K and leaving 142 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #156.

Alerus Investment Advisors first reported a position in NVS in Q4 2013 and has held it in 10 quarters since. The position peaked at $582K in Q4 2015. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

Alerus Investment Advisors held 142 shares of Novartis worth $9K as of Q1 2016.
Alerus Investment Advisors sold 8,035 Novartis shares in Q1 2016, an estimated $547K.
Novartis made up ﹤0.01% of Alerus Investment Advisors's portfolio in Q1 2016, its #156 holding.
Alerus Investment Advisors first reported a position in Novartis in Q4 2013 and has held it in 10 quarters since.
Alerus Investment Advisors's Novartis position peaked at $582K in Q4 2015.
876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.